Postprandial Glucose Improves the Risk Prediction of Cardiovascular Death Beyond the Metabolic Syndrome in the Nondiabetic Population
AUTOR(ES)
Lin, Hung-Ju
FONTE
American Diabetes Association
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2732157Documentos Relacionados
- Cardiovascular Risk and Metabolic Syndrome in Individuals with Mental Disorders
- Metabolic Syndrome and Risk of Cardiovascular Diseases in Female Breast Cancer Survivors
- Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen
- Cardiovascular disease and risk in the Aboriginal population
- Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study